RenehaVis is a means for modern treatment of all degrees of severity of arthrosis in knee and hip joints accompanied by joint pain and mobility issues.
Principle of treatment
RenehaVis is the only unique two-chamber injection that enables administration of two forms of hyaluronic acid in a single application. The significance of administering two forms of hyaluronic acid is linked to the complex effect: one form of hyaluronic acid (low molecular) ensures protection and repair (strengthening) of cartilage on joint surfaces and supports production of the body’s own acid, which is produced in healthy joints. The other form of hyaluronic acid (high molecular) ensures a mechanical effect.
Owing to its high viscosity and the combination of both forms of hyaluronic acid, RenehaVis significantly reduces friction and collisions in the joint and reduces pain both at rest and during movement and improves the mobility of the damaged joint.
RenehaVis is the only product in the world which contains 2 forms of hyaluronic acid (HA) in various sizes and concentration for application into the knee joint by injection. Only the presence of both forms of this acid ensures the closest approximation of the effect of the body’s own hyaluronic acid, which is produced in healthy joints under normal conditions.
RenehaVis is a modern and innovative product which has demonstrated better results than other products in studies – faster pain subsidence and shorter treatment cycles than competitive products. This is due to the presence of both forms of hyaluronic acid compared to all other products which contain either one form or the other (high or low molecular acid).
RenehaVis can be applied (and is suitable for application) even in early phases of joint osteoarthritis or other conditions related to joint cartilage damage. The sooner it is applied, the greater the chances of slowing down the process of arthrosis and improving symptoms, as there is still a sufficient amount of cartilage tissue in the joint that can be protected.
Considerable relief is also achieved in more advanced stages of osteoarthritis (stages II and III), where the high viscosity of large molecule hyaluronic acid comes into play along with its mechanical effect of “cushioning” and “lubricating” the joint.